Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Decision Analytics was a premier health economics and outcomes research (HEOR) and market access consultancy serving the global life sciences industry. The firm specialized in developing economic models, conducting systematic literature reviews, and providing strategic pricing and reimbursement advice to pharmaceutical and biotechnology companies. By leveraging advanced analytical techniques, Decision Analytics helped clients demonstrate the clinical and economic value of their products to payers and regulatory bodies. The company was acquired by Mapi Group in 2013, which was subsequently acquired by the global CRO ICON plc in 2017. Its expertise is now fully integrated into ICON's Global Health Economics and Outcomes Research division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Decision Analytics.